Top Markets
#1 GALA GALA +38.00%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +36.95%
#3 Magma Finance Magma Finance +34.28%
#4 Useless Coin Useless Coin +32.19%
#5 Stacks Stacks +31.85%
#6 Bless Bless +31.76%
#7 Binance-Peg ZEC Binance-Peg ZEC +29.81%
#8 Talus Network Talus Network +29.63%
#9 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +29.53%
#10 Zcash Zcash +29.42%
Coin of the day
GALA GALA
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
ERYTECH Pharma S.A. ERYTECH Pharma S.A.

ERYTECH Pharma S.A.

ERYP
Classifica tra le azioni #24694
ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on... ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on creating innovative therapies derived from red blood cells. These treatments target various types of cancer and rare (orphan) diseases, with the company operating in both France and the United States. Its primary experimental drug, eryaspase, is currently undergoing Phase 3 clinical trials for patients battling second-line pancreatic cancer. Furthermore, this candidate is also in Phase 2 development for triple-negative breast cancer and for individuals with second-line acute lymphoblastic leukemia. The company is additionally advancing erymethionase, a preclinical-stage product. This candidate utilizes methionine-gamma-lyase, encased within red blood cells, to specifically address cancers that are dependent on methionine for growth. Established in 2004, ERYTECH Pharma's corporate headquarters are situated in Lyon, France.
Prezzo delle azioni
$0.95011029
Ultima sincronizzazione: 2023-06-28
Capitalizzazione di mercato
$57.72M
Variazione (1 giorno)
8.53%
Variazione (1 anno)
0.00%
Paese
FR
Scambia ERYTECH Pharma S.A. (ERYP)

Categoria

Healthcare
Rapporto P/B per ERYTECH Pharma S.A. (ERYP)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di ERYTECH Pharma S.A., il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per ERYTECH Pharma S.A. da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH